Title: The Incidence and Prevalence of Dyslipidemia in Diabetic Patient in OP & IP of Annapoorana Medical College and Hospital
Authors: Dr S. Senthilnathan MD, Dr M N. Shyamala MD
DOI: https://dx.doi.org/10.18535/jmscr/v8i1.23
Abstract
Dyslipidemia contribute to major risk factor of atherosclerosis and consequent mortality in diabetic patients. It often seen after the onset of diabetes particularly type 2 DM and may persist inspite of adequate control of blood sugar. Diabetes Mellitus is the most common chronic disease present in the world. The leading causes of morbidity and mortality for such patients have been attributed to the rising incidences of Cardiovascular Diseases (CVD) as a complication of type 2 diabetes. A major proportion of CVDs are attributed to the occurrence of atherogenic dyslipidemia.
Objectives: 1, To know the incidence and prevalence of dyslipidemia in diabetic patient. 2, To know the incidence and prevalence of cardiovascular complication in dyslipidemic patient.
Material and Methods: This study is carried out among type 2 diabetic mellitus patients attending OP and IP of AMCH salem , spread over three month April –June 2019 .The total study of population is 200 which included known as well as newly diagnosed type 2 diabetic patients more than 30 years of age.
Result: Out of 200 patient who were included in the study 110 are female and 90 are male .ECG were taken to see any cardiovascular complication. In that , patient whose ECG were abnormal [ ST elevation ] had elevated total cholesterol 290.8 mgs/dl and triglycerides 339.8 mgs/dl .
Conclusions: Results suggest high (86%) prevalence of dyslipidemia among type 2 diabetes mellitus study subjects .From this study we have found out that dyslipidemia control in Indian T2DM patients is very poor. Dyslipidemia being one of the main risk factors for CVD in T2DM patients there it is mandatory to treat dyslipidemia aggressively to reduce risk of cardio vascular events.
References
- Sheshiah V, Balaji V. A handbook on Diabetes Mellitus. 6th ed. New Delhi: all india publishers & distributers. 2013:29-54.
- American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus, Diabetes Care. 2011,34,62-9.
- Ramachandran A, Snehalatha C. Current scenario of diabetes in India, J. Diabetes. 2009;1(1):18-8.
- Kondaveeti SB, Shekar AI, Kumar A, Palwan H, Raja G. Evaluation of glycated albumin and dyslipidemia in type-2 diabetes mellitus. International journal of Bioassays. 2012;01(11):112 -15.
- Rajput DP, Shah JY, Singh P, Jain S. Evaluation of dyslipidemia in type 2 diabetes mellitus. Asian Journal of Medical sciences. 2015;6(6):16-20.
- Agrawal Y, Goyal V, Chugh K, Shanker V, Singh A. Types of Dyslipidemia in Type 2 Diabetic Patients of Haryana Region. Sch. J. App. Med. Sci. 2014;2(4D):1385-92.
- Mukhopadhyay J, Kanjilal S, Biswas M. Diabetic dyslipidemia‑priorities and targets in India. Medicine Update. 2010; 20. Available from: http://www.apiindia.org/content_mu_2010.html [Last accessed on 2013 Aug 23].
- Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. ICMR–INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research‑India Diabetes (ICMR‑INDIAB) study. Diabetologia 2011;54:3022‑7.